Drug Trial Radar · NCT04371666
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Last checked: Nov 19, 2026Latest source record: Mar 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
98
Actual
Start
Aug 10, 2020
Primary completion
Feb 13, 2023
Study completion Aug 17, 2023
Sponsor
- Lead sponsor
- Kyntra BioIndustry
- Sponsor type
- Industry
- First posted
- May 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in participants with non-ambulatory Duchenne muscular dystrophy (age 12 years and older).
Conditions
- Duchenne Muscular Dystrophy
Interventions
PamrevlumabDrug
Pamrevlumab per dose and schedule specified in the arm description
PlaceboDrug
Matching placebo per schedule specified in the arm description
CorticosteroidsDrug
Systemic deflazacort or equivalent potency of corticosteroids administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Total Score of Performance of Upper Limb (PUL) 2.0 Version at Week 52Time frame: Baseline, Week 52
Locations
53 sites in 14 countries. Site status is shown where the registry gives one.
Arkansas Children's
Little Rock, Arkansas
University of California Los Angeles Medical Center
Los Angeles, California
UC Davis Health
Sacramento, California
Children's Hospital Colorado
Aurora, Colorado
Rare Disease Research, LLC
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Iowa
Iowa City, Iowa
University of Kansas Medical Center
Fairway, Kansas
Kennedy Krieger Institute
Baltimore, Maryland
UMASS Med School
Worcester, Massachusetts
C.S. Mott Children's Hospital
Ann Arbor, Michigan
Spectrum Health Hospitals Helen DeVos Children's Hospital
Grand Rapids, Michigan
Washington University School of Medicine in Saint Louis
St Louis, Missouri
Carolinas HealthCare System Neurosciences Institute-Neurology - Charlotte
Charlotte, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Shriners Hospital for Children
Portland, Oregon
Penn State Health Children's Hospital
Hershey, Pennsylvania
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Children's Health Dallas/UTSW
Dallas, Texas
University of Utah Health
Salt Lake City, Utah
Children's Specialty Group - Medical Center Office
Norfolk, Virginia
Seattle Children's Hospital
Seattle, Washington
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Klinik Favoriten
Vienna, Austria
Universitair Ziekenhuis Gent
Ghent, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Belgium
Centre Hospitalier Régional de la Citadelle
Liège, Belgium
London Health Sciences Centre
London, Ontario, Canada
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, China
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
Fakultní Nemocnice Brno - Dětská Nemocnice
Brno, Czechia
Klinika dÄ>tské neurologie, Neuromuskulární centrum
Prague, Czechia
CHU de Nantes - Hotel Dieu
Nantes, France
Association Institut de Myologie
Paris, France
Hopital Hautepierre
Strasbourg, France
The Chaim Sheba Medical Center
Tel Aviv, Israel
The Edith Wolfson Medical Center
Tel Aviv, Israel
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.